Nobelpharma
38
1
1
32
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
7.9%
3 terminated/withdrawn out of 38 trials
91.4%
+4.9% vs industry average
61%
23 trials in Phase 3/4
25%
8 of 32 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (38)
MSA-01 in Multiple System Atrophy
Role: collaborator
In-office Repair of Chronic Tympanic Membrane Perforations
Role: collaborator
Evaluating the Safety and Efficacy of Topical Sirolimus 0.2% to Treat Acanthosis Nigricans
Role: collaborator
A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection
Role: lead
Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers
Role: lead
Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With Endometriosis
Role: lead
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea
Role: lead
Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers
Role: lead
Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Role: lead
Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea
Role: lead
Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC
Role: lead
A Phase II/III Study of Sargramostim
Role: lead
NPC-06 to Pain Associated With Acute Herpes Zoster
Role: lead
A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I
Role: lead
Efficacy Confirmation Study of NPC-09
Role: lead
An Additional Study of NPC-22 in Healthy Adult Males
Role: lead
NPC-06 to Acute Pain in Herpes Zoster
Role: lead
Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer
Role: lead
A Study of NPC-22 in Healthy Adult Males
Role: lead
NPC-12G Gel 0.2% Sirolimus PK Bridging Study
Role: lead